Pharmaceuticals, Biotechnology, Vaccines
American multinational pharmaceutical + biotech corporation (NYSE: PFE). Vaccines, oncology, rare diseases, internal medicine. $58bn revenue 2023. 88,000+ employees. Pfizer Thailand manages innovative-medicines + vaccines portfolio plus oncology + rare-disease care programmes.
Composite score across 5 categories MNCs operating in Thailand can demonstrate.
How this is computed: a weighted average of 5 sub-scores. Higher weight on signals an MNC has agency over (Thailand venue depth, international disclosure framework adoption, DEI policy explicitness) and lower weight on audit / scale signals that depend on company size.
How Pfizer Inc.is showing up for Thailand's LGBTQ+ community
Inclusion Dividend
Not yet enrolled
Creator partners
0
verified Thai KOLs
Audit history
Last 2023
Thailand presence
Single market presence
PrideShow LGBTQ+ ESG score (global) — Thailand-specific signals are above
86
Platinum · A+
LGBTQ+ Policy
100
Supply Chain
75
Community
70
Reporting
100
HRC Corporate Equality Index 100% score (multi-year)
Bloomberg Gender-Equality Index constituent
OPEN @ Pfizer — LGBTQ+ Colleague Resource Group globally
2023 ESG Report — GRI / TCFD / CDP / SASB aligned
CDP Climate A-List (multi-year)
DJSI World + FTSE4Good Index constituent
Access Accord — 17 strategic access programmes for low-income countries
Signatory to UN Global Compact + Business Coalition for the Equality Act
Transgender-inclusive benefits + PFLAG partnership
2030 Bold Moves — accelerate access for 1bn+ patients
Pfizer Foundation — global health charitable initiatives
Reach Pfizer Inc.'s Thailand and APAC teams through PrideShow. Whether you're an NGO with a partnership idea, an SME on the supplier path, or a fellow MNC exploring co-activation — start the conversation here.
Is this your company?
Claim the listing to manage your Thailand inclusion evidence, respond to inbound enquiries, and connect with NGO and creator partners. Or sponsor PrideShow 2026 directly.
